| Treatment time | NO | MDA (ng/ml) | ACTH (pg/ml) | NE (pg/ml) | |||
| Control group | Treatment group | Control group | Treatment group | Control group | Treatment group | ||
| pre-treatment | 50 | 112.35 ± 62.87 | 117.58 ± 63.37 | 36.43 ± 4.71 | 33.84 ± 4.73 | 420.04 ± 674.75 | 392.93 ± 592.84 |
| 1 week | 50 | 90.82 ± 62.58 | 89.32 ± 59.32 | 76.66 ± 10.40 | 83.23 ± 10.19 | 302.54 ± 591.01 | 314.74 ± 594.27 |
| 4 week | 50 | 76.04 ± 60.85 | 68.59 ± 51.73 | 109.82 ± 15.72 | 131.94 ± 23.57 | 242.53 ± 543.61. | 265.81 ± 590.27 |
| 3 months | 50 | 60.42.33 ± 53.64 | 45.91 ± 38.94 | 184.89 ± 24.07 | 190.07 ± 29.83 | 185.31 ± 417.91 | 243.85 ± 588.45 |
| Analysis of variance F |
| 150.368 | 749.956 | 1252.012 | |||
| Analysis of variance P |
| 0.000 | 0.000 | 0.000 | |||
| Interaction |
| 3.439 | 10.656 | 8.157 | |||
| Interaction |
| 0.024 | 0.000 | 0.000 | |||